Tabunda, Gemalyn .
HRN: 11-30-00 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/06/2023
CEFUROXIME 1.5GM (VIAL)
04/06/2023
04/07/2023
IVTT
1.5mg
Q8 Hours
AGE With Mod DHN
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes